chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A little over 24 hours after receiving her vaccine, patient broke out in hives on her forehead, right eyelid, left cheek, nose, and chin. The hives lasted for almost two weeks.  She was constipated for a week and a half after the vaccine, a problem she has never had before as she usually goes once a day. When she finally had a bowel movement it was runny and frequent, up to 5 or 6 times a day for a few days.  One week after the vaccine, as some of the hives were beginning to go away, she had an eczema breakout. Her skin was red and hot where patches of eczema were popping up. It was on her arms, legs, small spots on her back, and on her cheeks. In the creases of the backs of her knees and her ankles the skin would crack and bleed.  Almost a month has passed and the eczema has not gone away. Her skin stays rough in patches on her arms and legs and has flared up 2-3 times, lasting 3-4 days each time when it gets very red and hot and seems to itch. She still doesn?t have bowel movements regularly and gets very fussy. I called the pediatrician?s office after the reactions began and have sent them pictures of the hives but they did not need to see me in the office and no treatment was given. I have used moisturizer for the eczema daily.
Patient received pediatric Pfizer indicated for 5-11yo but she is actually 13yo.  Patient?s mom contacted and informed that she will receive regular Pfizer for second dose.
AFLURIA given on 8/16/2013. Significant redness, hardness, bruising, warm to touch at site. Area demarcated 3 inch in diameter. Also occurred last year with FLUZONE 2013.
I have not been tested but I have lost my taste and smell this past week so, I am assuming that I also have it; I have not been tested but I have lost my taste and smell this past week so, I am assuming that I also have it; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection,( lot number and Expiry date: unknown) (age at the time of vaccination was 61 years), via unspecified route on 10Mar2021 as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medication was not reported. The patient and her husband received the vaccine on 10Mar2021. The caller would like to know efficacy of vaccine after first dose. The patient had lost her taste and smell this past week so, the patient was assuming that also i have it. The patient not have been tested but lost the taste and smell this past week so. They want to cancel their Wednesday second vaccine. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
COVID symptoms: fever, aches, shortness of breath, chest pain, swollen lymph nodes, extreme fatigue
Patient was called back to the clinic and vital signs were taken and were WNL. Patient showed no s/s of any distress and when asked he states no s/s. Provider was notified and also Moderna manufacture and they will update with guidelines. Patient was release back to security.
1st dose - tingling "cold" in left arm and leg within 15min of  administration; 1st dose - tingling "cold" in left arm and leg within 15min of  administration; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Aug2021 11:00 (Lot number: EW0181) at the age of 53 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "known allergies: yes" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE. The following information was reported: PARAESTHESIA (non-serious), FEELING COLD (non-serious) all with onset Aug2021, outcome "not recovered" and all described as "1st dose - tingling "cold" in left arm and leg within 15min of  administration". It was unknown if therapeutic measures were taken as a result of paraesthesia, feeling cold.  Additional information: It was unknown that patient received treatment. Patient did not any received other vaccines prior vaccination. Patient did not tested for covid Post vaccination.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a certified medical assistant refers to a 19 year old female patient. The patient had no concomitant medications, no known allergies and pertinent medical history. On 02-DEC-1998, the patient was vaccinated with first dose of VARIVAX (strength, dose, route, site, lot#, expiry date were not reported). On 29-MAR-2007, the patient was vaccinated with second dose of VARIVAX (strength, dose, route, site, lot#, expiry date were not reported). ON 19-MAY-2015, the antibody test was drawn, and it was not reactive to varicella. Negative antibody test was the reason for administration on 15-JUL-2015, the third booster dose of VARIVAX (strength, site, route, dose were not reported) (lot # J008441, expiry date 09-JUL-2015). The reporter stated that it was expired dose of VARIVAX administered. The treatment for adverse event was not given. Therapy was not discontinued. The outcome of the adverse events was not reported. The relatedness between VARIVAX and the events was not reported. Additional information has been requested.
On 1/18/00, the pt was dx'd with chickenpox. Unspecified medical attention was sought. Follow-up information reported that the pt subsequently, recovered.
Shingles; Heat rash; hives.; This is a spontaneous report from a contactable consumer or other non hcp.  A 53-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 21Jul2021 13:00 (Age at vaccination 53 years old) (Batch/Lot Number: Ew0128) as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included herpes virus infection from an unknown date and unknown if ongoing.  There were no concomitant medications. Treatment with Valacyclovir, covid prior vaccination and covid tested post vaccination was no. On an unspecified date the patient experienced Shingles Heat rash/hives. Therapeutic measures were taken as a result of shingles (herpes zoster), heat rash (miliaria), hives. (urticaria). Outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
renewed energy; more energy than ever; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (renewed energy) and ENERGY INCREASED (more energy than ever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 030L20A) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), TURMERIC [CURCUMA LONGA RHIZOME] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 07-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (renewed energy) and ENERGY INCREASED (more energy than ever). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (renewed energy) and ENERGY INCREASED (more energy than ever) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was details included.
a few days after the 1st I had intestinal discomfort, two days later I was passing only mucus, two days later blood was mixed with the mucus.  two days later it was mostly blood.  After the 2nd dose, the bleeding increased and went to 100% blood.  The bleeding lasted a total of 18 days.  My GI appointment was a few days later.
24MAR92 5AM t104-high pitched scream lasted 1/2 hr; lethargic all day but drinking fluids well; getting tepid baths for temp & APAP Q 4 hrs; responsive; mom called MD; 25MAR pt fully recovered;
Patient was delirious and unresponsive for ~ 90 seconds about two minutes after given the vaccines.   A couple of minutes prior, the patient was complaining of feeling dizzy and hot.  I went to fetch the patient a bottle of water.  When I returned, the patient was minimally responsive for a moment, then went unresponsive.   911 was promptly called, the emergency pack, with EpiPen was about to be prepared, and then the patient started to come back to coherence.  Paramedics arrived within 5 minutes, evaluated the patient for ~20 minutes, and departed as a result of patient refusing continued care.
Tossing & turning, couldn?t sleep, had severe ?charlie horse? in my left calf that had me sit up in bed yelling in pain. Was very thirsty & hot. Got out of bed to turn on fan & felt like I had the spins. Was very dizzy & nauseous. Walked out to kitchen to fill up water bottle & couldn?t even stand for 30 seconds. Went into a full body sweat. Ran to bathroom & started throwing up. Clothes were soaked in sweat, started shaking, then was freezing. Felt a sudden need to have a BM. Had a BM with intense pain in stomach & sweating. Then started throwing up again followed by another BM. Went to bedroom bathroom & was crying, yelling out in pain from severe pain in stomach. Felt like I was going to pass out. Had another BM. Slept on bathroom floor with heating pad and teeth were literally chattering and body involuntarily shaking from being cold. Had severe migraine next day, missed two days of work, stayed in bed all day with extreme muscle/body aches, fatigue, extreme weakness, nauseous, & headache. This is the 3rd day of symptoms & I still am too weak to get out of bed for longer than to use the bathroom. Headache behind eyes, sore, and tired.
Slight fever then painful screaming for 6 hours straight. Screaming was non-stop. This was not a normal cry, fussy cry. This was a high pitched screaming.
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Severe, Systemic: symptoms consistent with serotonin syndrome, likely  unrelated to vaccine after discussion with caregiver-Medium, Systemic: Headache-Medium, Systemic: Tachycardia-Medium, Systemic: Tingling (specify: facial area, extemities)-Severe, Additional Details: Pt on multiple sertonergic agents and additionally admitted to taking st john's wort, which was never discussed with psych or pharmacy. Pt never had trouble breathing and was released with husband and 2 caregivers with instructions to call MD immediately and report to ER. Not likely related to vaccination, however reporting just in case. symptom onset was almost immediately after vaccination.
Per admitting documentation: Pt with history noted above, presents with cough over last 7 days. Initially productive though has been dry cough for past 3-4 days. Yesterday, pt experienced debilitating fatigue, he went to take a nap and upon waking, was so weak he was unable to get up out of bed, thus calling EMS, prompting presentation today. States this weakness developed yesterday but was fine before. No fever or chills, chest pain. Does admit to leg swelling which he states is new for him.      Clinical Summary Patient was admitted to MedSurg for further management of COVID-19 pneumonia with acute hypoxic respiratory failure.  He was started on Decadron and remdesivir.  E consult for infectious disease was obtained, recommended continue remdesivir x5 days and Decadron x10 days.  Patient was placed on scheduled albuterol HFA.  On admission he had some mild volume overload secondary to acute on chronic HFrEF and received 2 doses of IV Lasix with significant improvement.  His oxygen requirements continue to improve throughout his hospital stay and at the time of discharge he was found to not require any oxygen on 6-minute hall walk test.  His lungs sound improved throughout his hospital stay and he had no active wheezing at the time of discharge.  Patient continued to have significant generalized weakness.  Physical therapy was consulted and worked with patient throughout his hospital stay and at the time of discharge she was near his baseline.  He did decline discharged to SNF.  Care management was consulted for assistance with discharge planning.  Patient was discharged home on 9/28 in stable condition.  He had completed 5 days of remdesivir.  He is continued on Decadron to complete a total of 10 days.  Patient's renal function had returned to baseline.  He is instructed to follow-up with his primary care provider within the next 7 days.   Discharge diagnosis COVID 19 pneumonia - resolved, completed remdesivir, DC on decadron to complete 10 days  AECOPD -resolved  Acute on chronic HFrEF - resolved  AKI on CKD IIIb - resolved, Cr at baseline Essential hypertension History of CAD MDD Generalized weakness Deconditioning
FBE reports that he learned of the AE on 3/3/2023. FBE reports that a patient developed a rash after receiving their second dose of GARDASIL 9.; This spontaneous report was received from field-based employee (FBE) on behalf of a physician assistant and refers to an adult female patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unknown date, the patient was vaccinated with the second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis. On an unknown date, the patient developed a rash. She fully recovered and there was no need for any medical intervention. The patient did not elect to receive a third dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9).  Causality assessment was not provided.
Development of cellulitis in right shoulder/arm; treatment was 10 day course of antibiotic Doxycycline; currently still on antibiotic.
kidney stone problem really bad; low fever; running in temperature; This spontaneous case was reported by a consumer and describes the occurrence of RENAL COLIC (kidney stone problem really bad), PYREXIA (running in temperature) and PYREXIA (low fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 010M20A) for COVID-19 vaccination.     The patient's past medical history included Kidney stone (she had 2 kidney stone 15 years ago reported.). Concurrent medical conditions included Drug allergy (Allergic to a lot of drugs, Vitamins Reported.).   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021 at 5:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (running in temperature). On 10-Mar-2021, the patient experienced RENAL COLIC (kidney stone problem really bad) and PYREXIA (low fever). At the time of the report, RENAL COLIC (kidney stone problem really bad), PYREXIA (running in temperature) and PYREXIA (low fever) outcome was unknown.            No Concomitant medications were reported. No treatment medications were reported. Action taken with mRNA-1273 in response to the events was not Applicable
Starting the evening of Sept 26th , several hours after receiving the vaccine,  I felt very tired and totally out of energy.  Slept very restless that night .  The following two days I developed a low grade fever, had diarrhea  and stomach  cramps .  The symptoms finally went away on the 3rd day.
Information has been received from a physician concerning a male who was in his mind 50s was vaccinated with a 3 dose series of RECOMBIVAX HB. Because the patient works at a local jail a titer was done but it was 3. One booster dose of RECOMBIVAX HB was given 6 months later. The titer after that dose was 4.9. Medical attention was sought. As of 19-Apr-2007 it was reported that the patient was not recovered. No product quality complaint was involved. Additional information has been requested.
Right side numbness, tingling, weakness, felt like icy hot all of right side of my body, fatigue. Slight burning, numbness tingling  left foot. Muscle spasms under both rib cages/diaphram.
Temp of 104 degrees without any other infections. Apprx. 6 hours after vaccine administered.
severe refractory Headache for more than one month; Cannot not bend down or perform normal ADLS; This is a spontaneous report from a non-contactable nurse (patient). An adult non-pregnant female nurse patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 13Dec2020 as dose number unknown, single for covid-19 immunisation. The patient's medical history reported as none and concomitant medications were not reported. No known allergies reported. No other vaccine in four weeks. No covid prior vaccination. On 20Dec2020, the patient experienced severe refractory headache for more than one month, cannot not bend down or perform normal ADLs (activities of daily livings). The patient underwent lab tests included on COVID-19 virus test with result unknown (Nasal Swab) on 11Jan2021 and CT scan; Result unknown on an unspecified date. The patient had taken Ibuprofen, and tylenol every 8 hours (treatment). The outcome of the event was recovered with sequel.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
PATIENT THREW UP AFTER VACCIANTION. PT ALSO WAS DIZZY. PT MENTIONED THAT IT MIGHT ALSO BE DUE TO ANXIETY
low grade fever and chills for about 18 hours, body aches and extreme fatigue for about 36 hours, Developed cold sore. Loss of appetite  for about 24 hours. Dull headache for 3-4 days after
Rash, redness and swelling at injection site. Began day after and persists 1 week later.
11/7/08 day of vaccine - note routine soreness and bruising at injection site. 11/13/08c/o left arm pain at injection site. 11/19/08 check arm no swelling,  no induration, no bruising - pain at site. 12-2-08 went to doctor on ER for arm pain - R/O pinch nerve vs muscle infection.
Patient presented to the pharmacy for her second Moderna COVID-19 vaccine. Patient was unable to fill the form out herself, so I had to assist the patient with the questions. Patient stated she had no problems with her first Moderna vaccine 4 weeks ago. I asked the patient how she felt post injection and she stated she did not feel the injection. Patient rolled down her arm sleeve and when I felt her shoulder to make sure the bandage was not removed, the patient stated her arm felt sore. I advised the patient to wait at least 15 to 30 minutes to make sure she felt okay. Patient walked to observation area and sat with her mother. Approximately 10 minutes later, mom told a technician at the register she thought the patient was having an "allergic reaction".  The technician alerted me (the pharmacist) and I immediately went to the patient to determine the situation. Mom stated patient was "having trouble talking", which is what happens when patient is having an allergic reaction. My staff called a code white to have management come to the pharmacy for assistance and also called EMS/911. I advised mom and patient I could give liquid Benadryl & mom agreed (patient shook her head yes). I then attempted to administer 5 mL of Diphenhydramine (12.5mg/5mL) to the patient using an oral syringe; I was only able to give the patient about 2mL before patient shook her head that she did not want anymore medication and made a face as if the medication tasted bad. About a minute later patient started holding her head between her hands stating her head hurt. Patient was becoming pretty agitated and I asked if mom and patient about moving the patient to the floor. Mom stated no, that placing her on the floor would make the head pain worse. Within a few minutes, patient appeared to be having a seizure. We then moved the patient from the chair to the floor and placed patient on her side in case she vomited. Patient did not vomit but had a little bit of spit up. It then appeared the patient had stopped breathing. At this point, patient was placed on her back and three chest compressions were given. Patient immediately started breathing. EMS arrived at this point and gave Versed IM because the patient was starting to have yet another seizure. Patient was then transported by EMS to the hospital. Patient left the pharmacy awake and more coherent of her surroundings after receiving the Versed and the seizure had stopped.
Patient complained of a raised red bump, warm to the touch and itchy in the area of the injection site, starting within minutes of the immunization. Patient self-monitored condition over next 2 days, states condition has improved as of 8-1-18. Unknown if patient used any medication to treat condition.
pt recv vax; woke up w/ very weak legs which spread to arms and rest of body, lasted 2 days;
an Increased blood  (previous was average 128/90; after vaccine is average 140/100). As of now the increased values are still there.Heartbeats increased by about 15/20 bpm;; Heartbeats increased by about 15/20 bpm; as of now the increase is still there; Headaches started from first dose and are still there.; Tingling sensation on hands and legs, from 1st dose till currently; This is a spontaneous report from a contactable consumer (female patient). A 69-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6208, expiry date: unknown) via unspecified route of administration on an unspecified date in Mar2021 (age at vaccination: 69-years) as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EW0150, expiry date: unknown) via unspecified route of administration, in left arm on 05Apr2021 (age at vaccination: 69-years) as dose 2, single for Covid-19 immunisation. Medical history included hypertension, cerebral vasculopaty, Hashimoto's disease (Thyroid) from an unspecified date and unknown if ongoing. Concomitant medications were not reported. Patient was not pregnant at the time of vaccination. There were other prescribed medicines in two weeks. No other vaccine in four weeks was administered to patient. On 05Apr2021, after first dose there was an Increased blood (previous was average 128/90; after vaccine is average 140/100). As of now the increased values are still there. Heartbeats increased by about 15/20 bpm; as of now the increase is still there. Headaches started from first dose and are still there. Tingling sensation on hands and legs, from 1st dose till currently. Treatment was not given as a result of the adverse events. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient underwent lab test which included blood pressure measurement, with results as 140/100 mmHg and 128/90 mmHg, and heart rate with results as increase, on an unspecified date. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 14-JUL-2022 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 14-JUL-2022, the patient experienced pain at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain at injection site on 14-JUL-2022. This report was non-serious.
Pt is here for Shingrix #2 only.   Redness, swelling on left arm below injection; about 5" by 1" red patch; warm to the touch.